pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,972 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 17 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,346
  • earnings287
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06282406: Pupil-Indexed Noninvasive Neuromodulation

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Paresis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04356287: Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis

    Sponsor: Marie Hudson, MD. Phase: PHASE1. Conditions: Sclerosis, Systemic, Mesenchymal Stem Cells

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07640516: The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Ultrasound Guided Peripheral Nerve Blocks as a Solo Anesthetic Technique in High Risk Patients Undergoing Unilateral Above Knee Amputation .

    Sponsor: Kasr El Aini Hospital. Phase: NA. Conditions: Analgesia Assessment, Above Knee Amputation, Fentanyl vs Dexmedetomidine

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07095504: A Study of Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Cardiovascular Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06627504: Type 1 Diabetes REst for Metabolic Health

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Type 1 Diabetes (T1D), Sleep Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04173104: PET and MRI Imaging of Brain Tumors Using [18F]PARPi

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: Brain Tumor, Brain Cancer

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07663604: Assessment of Pain Experience in Fibromyalgia

    Sponsor: Zülal TATAR. Phase: . Conditions: Pain, Fybromyalgia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06962306: Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery

    Sponsor: Duke University. Phase: PHASE4. Conditions: Cleft Palate, Pain, Postoperative Care, Perioperative Care, Children

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07336706: The Effect of Escape Room Simulation on Nursing Students' Knowledge and Academic Self-Efficacy Regarding Stoma Care

    Sponsor: Ankara Yildirim Beyazıt University. Phase: NA. Conditions: Stoma, ESCAPE ROOM

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07426406: Oral Nutritional Supplement in Adults With or at Risk of Malnutrition

    Sponsor: Abbott Nutrition. Phase: NA. Conditions: Gastrointestinal Tolerance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06551116: QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

    Sponsor: Abramson Cancer Center at Penn Medicine. Phase: . Conditions: HER2-positive Metastatic Breast Cancer

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07478406: Relatıonshıp Between Pelvıc Floor and Venous Insuffıcıency

    Sponsor: Istanbul Arel University. Phase: NA. Conditions: Chronic Venous Insufficiency, Pelvic Floor, Exercise

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07423806: Evaluation of Modified Le Fort I Osteotomy for Treating Cleft Lip and Palate Patients

    Sponsor: Alexandria University. Phase: PHASE4. Conditions: Cleft Lip Palate, Class III Skeletal Malocclusion, Le Fort; I

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07387614: WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME

    Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Caregivers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07258121: Study of ZGGS34 in Participants With Advanced Solid Tumors

    Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Phase: PHASE1. Conditions: Solid Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07697521: Clinical Characteristics, Treatment Patterns, and Outcomes of Hospitalized Patients With Refractory Inflammatory Bowel Disease

    Sponsor: Shanghai 10th People's Hospital. Phase: . Conditions: Inflamatory Bowel Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06630806: A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

    Sponsor: Sanofi. Phase: PHASE1. Conditions: Plasma Cell Myeloma Refractory

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04886804: Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Neoplasm Metastasis, Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07574216: VEDA Study (DHEA vs Estradiol)

    Sponsor: University of Arizona. Phase: NA. Conditions: Post-menopause, Pre-menopause, Sexual Function, Menopause, Vaginal Dryness, Painful Intercourse

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07471906: Compliance to Vaccination in Children With Diabetes and Their Siblings

    Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07357506: Reducing Skin Side Effects in Patients Receiving Radiation on Tomotherapy

    Sponsor: King Faisal Specialist Hospital & Research Center. Phase: NA. Conditions: Head and Neck Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07653204: Contactless Ultrasound Data Acquisition in Emergency Departments to Discriminate the Origin of Dyspnea and Chest Pain

    Sponsor: Austral Diagnostics. Phase: . Conditions: Dyspnea, Chest Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06698406: Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale

    Sponsor: Benno Rehberg-Klug. Phase: . Conditions: Pain, Chronic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04479306: Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06092216: Spesolimab in Pyoderma Gangrenosum

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: PHASE2. Conditions: Pyoderma Gangrenosum

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07274514: Virtual Reality on Balance of Parkinson's Disease

    Sponsor: Instituto de Investigación Sanitaria Aragón. Phase: NA. Conditions: Parkinson Disease (PD), Immersive Virtual Reality, Physical Therapy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06045806: A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

    Sponsor: Celgene. Phase: PHASE3. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04506606: Cardiac Rehab Effects in HFpEF

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05413304: Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Glioma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06841614: EBOla Post-Exposure Prophylaxis

    Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE3. Conditions: Ebola Virus Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07485114: Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

    Sponsor: Daniel Keizman. Phase: . Conditions: Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Transitional Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04120714: Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Pathological Use of Internet Games

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07027306: The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

    Sponsor: AO Foundation, AO Spine. Phase: . Conditions: Osteoporotic Fractures, Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06860516: HLA Demographics Study in Adults With Type 1 Diabetes

    Sponsor: GentiBio, Inc. Phase: . Conditions: Diabetes Mellitus, Type I

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07700316: Compare the Effect of Radiofrequency (TECAR) and Ultrasound on Sensation, Hand Dexterity, and Quality of Life in Patients With Carpal Tunnel Syndrome.

    Sponsor: Delta University for Science and Technology. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04198116: Combining Varenicline and Guanfacine for Smoking Cessation

    Sponsor: Yale University. Phase: PHASE2. Conditions: Smoking Cessation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06666504: The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

    Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: . Conditions: Severe Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05696704: Telehealth to Reduce Mental Health in Family Caregivers

    Sponsor: Texas Tech University. Phase: NA. Conditions: Mental Health Issue, Grief, Burden, Caregiver

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07048314: Stem Cells for Erectile Dysfunction Post RALP

    Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Erectile Dysfunction, Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07344116: Hepatobiliary and Pancreatic Tumor Biobank

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: . Conditions: Hepotacellular Carcinoma, Cholangiocarcinoma, Pancreatic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451106: Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics

    Sponsor: University of California, San Francisco. Phase: . Conditions: Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction, Bladder Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03510104: Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

    Sponsor: Meryx, Inc.. Phase: PHASE1. Conditions: Advanced Cancer, Metastatic Cancer, Neoplasms, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05886504: Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users

    Sponsor: ANRS, Emerging Infectious Diseases. Phase: NA. Conditions: Psychiatric Disorder, Drug Use

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06849804: Comparing the Efficacy of Ultrasound Guided Erector Spinae Plane Block, Ultrasound Guided Caudal Block, and Local Infiltration for Postoperative Pain Control in Pediatric Patients Undergoing Unilateral Inguinal Hernia Repair as a Day-Case Surgeries: A Randomized Controlled Trial

    Sponsor: Tanta University. Phase: NA. Conditions: Analgesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626516: Tebentafusp-tebn With LDT in Metastatic UM

    Sponsor: Thomas Jefferson University. Phase: PHASE1. Conditions: Metastatic Uveal Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07701616: Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder

    Sponsor: Central South University. Phase: NA. Conditions: Obsessive-Compulsive Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06030206: Lung Transplant READY CF 2: A Multi-site RCT

    Sponsor: University of Washington. Phase: NA. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06459024: Master Framework For Relapse or Refractory Acute Myeloid Leukemia

    Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS. Phase: . Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07440823: Effects of Accentuated Eccentric Versus Concentric Training in Fast Bowlers

    Sponsor: Riphah International University. Phase: NA. Conditions: Sports Physical Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05447923: Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Colorectal Carcinoma

    full page →ctgov ↗
    ← prev
    page 89 of 100
    next →